Single and Multiple Ascending Oral Doses of Avenanthramide

NCT06101784 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Inflammation

Interventions

DRUG: Avenanthramide
DRUG: Placebo

Sponsor

Montreal Heart Institute

Collaborators

[object Object]
[object Object]